SOURCE: BDI Pharma, Inc.

BDI Pharma, Inc.

November 08, 2010 15:30 ET

Biotech Distributor BDI Pharma Launches "Connect"; Continues Expansion Through SAP Implementation

COLUMBIA, SC--(Marketwire - November 8, 2010) -  BDI Pharma, Inc. (BDI), the nation's fastest growing national distributor of biotech therapies, announced the launch of CONNECT, the company's internal implementation process culminating in the transition to SAP as the ERP & Customer Relationship Management system for BDI Pharma.

"As a solutions-based organization with specialized initiatives requiring different levels of integration, it was paramount that BDI Pharma select a platform like SAP," explained Tim Larson, VP of IT for BDI Pharma. "Successful implementation of our CONNECT project will offer the company the greater efficiency, flexibility and capability necessary to meet our corporate goals."

"BDI's tremendous success and aggressive growth plans have simply brought us to the limits of our legacy system," stated Tom Wood, Executive Vice President. "Through careful analysis and a keen eye on our future, we, as a company, have decided that SAP provides the foundation on which we must build the next chapters of our business."

About BDI Pharma, Inc.

Since 1995, BDI Pharma has defined its customer-centric approach to serving the nation's healthcare community through innovative inventory supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent need delivery. An open-access resource for reference material, educational literature, market data and online ordering, www.bdipharma.com has become an industry-renowned point of reference. Proprietary programs for veterinarians (www.4legpharma.com), product consignment (www.consignadvantage.com), flu vaccine pre-booking (www.securiflu.com), vaccine ordering (www.securivax.com) and purchasing/reward programs (www.qoreprogram.com and www.securigam.com) round out a family of solutions tailored to the needs of the healthcare community at large.

BDI Pharma's portfolio includes branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, IVIG, coagulation factors, high-titer or "hyper" immune globulins, and other specialty injectables. BDI Pharma is recognized as an "ADR," or Authorized Distributor of Record, for all of the manufacturers it represents.

Contact Information

  • Contact:
    Brad Davis
    Assistant Vice President, Marketing
    (800) 948-9834